V
Velocity Clinical Research | Norfolk, NE
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RTA 901
Dotinurad
Xanthine
BIIB143
Parent organization
This site is a part of Velocity Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 11 total trials
The primary objective of this trial is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 in participants with gout w...
Enrolling
Gout
Drug: Dotinurad
Other: Placebo
Trial sponsors
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems